scientifyRESEARCH
research funding database

RESEARCH FUNDING

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

2023 Global Migraine Research Grant

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The 2023 Global Migraine Research Grant from Pfizer supports migraine research worldwide, specifically:

  • Research on the therapeutic application of an oral CGRP antagonist, rimegepant, in migraine, headache, and other diseases where CGRP antagonism may be of clinical benefit
  • The development of tools for clinicians and patients to improve the care of migraine patients
  • Research regarding health disparities associated with migraine

The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or an advanced degree in Pharmacy, Physiotherapy, Psychology, Social Work or Public Health. Applicant must be affiliated with a host institution. Applicants may apply for up to 500,000 USD, including up to 28% in overhead costs.

Letters of intent have been extended to March 1, 2023. Invited full applications are due in June 2023.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
scientifyRESEARCH
monthly funding newsletter

unsubscribe at any time